Work

Clonal Hematopoiesis

Year: 2018

Type: review

Abstract: The most important prognostic factor for atherosclerotic cardiovascular disease is age, independent of all other recognized risk factors. Recently, exome sequence analyses showed that somatic mutations in blood cells, a process termed clonal hematopoiesis, are common and increase in prevalence with age, with at least 1 in 10 adults older than 70 years affected. Carriers of clonal hematopoiesis have been shown to be not only at heightened risk for hematologic malignancy but also at increased risk for atherosclerotic cardiovascular disease. Here, we review the prior literature of clonal selection and expansion of hematopoietic stem cells and the evidence supporting its causal association with atherosclerotic cardiovascular disease.

Source: Circulation Genomic and Precision Medicine

DOI: 10.1161/circgen.118.001926

Authors: Pradeep Natarajan, Siddhartha Jaiswal, Sekar Kathiresan